Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109196) titled 'Effect of Almond Consumption on non-alcoholic fatty liver' on April 23.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Stratified block randomization Method of allocation concealment:Centralized Blinding and masking:Open Label

Primary Sponsor: Almond Board California, USA

Condition: Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Intervention: Intervention1: Roasted Unsalted Almonds: Almond intervention low dose Intervention name: 42 g per day almond group Detail: Participants recei...